Marinus Pharmaceuticals Inc. buy BiotechBee
Start price
01.10.24
/
50%
€1.67
Target price
31.07.27
€3.00
Performance (%)
-79.04%
End price
27.10.24
€0.35
Summary
This prediction ended on 27.10.24 with a price of €0.35. Massive losses of -79.04% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Marinus Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to BiotechBee what are the pros and cons of Marinus Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Marinus Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Marinus Pharmaceuticals Inc.
Buy beendet
Stopped prediction by BiotechBee for Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.57
29.09.24
29.09.24
€3.00
30.06.27
30.06.27
6.37%
01.10.24
01.10.24
Could be very worthwhile Investment >20% year
Marinus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.22
08.09.24
08.09.24
€4.00
31.05.27
31.05.27
28.69%
29.09.24
29.09.24
Could be very worthwhile Investment >20% year

